{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:47:58Z","timestamp":1792266478518,"version":"4.4.0"},"reference-count":43,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Obesity affects millions of U.S. adults and is linked to cardiometabolic disease. This study examined whether user engagement with the Signos app, which combines artificial intelligence (AI) and continuous glucose monitoring (CGM), is associated with weight loss.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This study included adults (\u226518 years) with BMI \u2265 30 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      and without diabetes who enrolled in the Signos System, a platform integrating CGM data with AI-driven behavioral recommendations informed by glucose responses, dietary intake, physical activity, and user-entered data. Engagement was quantified as total meaningful actions per day (TMAPD). Longitudinal within-participant analyses compared weight change during engaged (TMAPD &gt; 0) and nonengaged (TMAPD = 0) periods among 3007 participants, expressed as weight loss percentage per week (WLPW%). Cross-sectional analyses evaluated 180-day total body weight loss (TBWL) among 1147 participants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In this longitudinal cohort, weight loss was greater during periods of engagement than non-engagement (1.17% \u00b1 0.04% vs. 0.44% \u00b1 0.03% per week;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Weight loss during engaged periods did not differ significantly between early and late engagers (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). In the 180-day cohort (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1,147), mean TBWL was 5.14% \u00b1 0.19%. Participants with higher engagement (TMAPD \u2265 1.02) achieved 5.90% \u00b1 0.25% TBWL compared with 4.38% \u00b1 0.23% in the lower engagement group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Greater engagement with the Signos System was associated with greater weight loss in adults with obesity and without diabetes. Weight loss outcomes were similar regardless of whether engagement occurred earlier or later during platform use. These findings suggest that engagement with AI-guided, CGM-informed behavioral interventions may support clinically meaningful weight reduction. Approved by the WCG Institutional Review Board (protocol no. 20212524) and conducted in accordance with the Declaration of Helsinki.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15209156261459741","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:26:42Z","timestamp":1781328402000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Engagement with an AI- and CGM-Integrated Digital Health Platform Is Associated with Clinically Significant Weight Loss"],"prefix":"10.1177","author":[{"given":"William","family":"Dixon","sequence":"first","affiliation":[{"name":"Signos, Palo Alto, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kim","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace E.","family":"Shryack","sequence":"additional","affiliation":[{"name":"Signos, Palo Alto, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Levonian","sequence":"additional","affiliation":[{"name":"Signos, Palo Alto, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Gusz","sequence":"additional","affiliation":[{"name":"Signos, Palo Alto, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharam","family":"Fouladgar-Mercer","sequence":"additional","affiliation":[{"name":"Signos, Palo Alto, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-8110","authenticated-orcid":false,"given":"Jay S.","family":"Skyler","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, University of Miami, Miami, Florida, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2400229"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.12.012"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000973"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020485"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18080"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2023.10.002"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12299"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2025.0165"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-023-00956-y"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02265-4"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-025-01967-3"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu17162695"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12966-024-01622-6"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.2196\/20283"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.2196\/66887"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20821"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2006.84"},{"key":"e_1_3_3_19_1","unstructured":"18.NHLBI Obesity Education Initiative Expert Panel on the Identification E. Summary of evidence-based recommendations. In: Clinical Guidelines on the Identification Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report. National Heart Lung and Blood Institute; 1998. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK2009\/ [Last accessed: March24 2026]."},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1571362"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-02036-9"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/19322968251337479"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-026-03920-0"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0222"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.2196\/45469"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.5993\/AJHB.43.4.12"},{"key":"e_1_3_3_27_1","doi-asserted-by":"crossref","unstructured":"26.Journal of Medical Internet Research - Web-based digital health interventions for weight loss and lifestyle habit changes in overweight and obese adults: Systematic review and meta-analysis. Available from: https:\/\/www.jmir.org\/2019\/1\/e298\/?utm_source=chatgpt.com [Last accessed: March24 2026].","DOI":"10.2196\/jmir.9609"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12966-024-01692-6"},{"key":"e_1_3_3_29_1","unstructured":"28.CDC. Steps for losing weight. Healthy Weight and Growth. 2025. Available from: https:\/\/www.cdc.gov\/healthy-weight-growth\/losing-weight\/index.html [Last accessed: March24 2026]."},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.5812\/ijem.13249"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1017\/S000711452000224X"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-022-00470-4"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2022.886783"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-025-01746-0"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/19322968251384318"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2024.0579"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/foods11121754"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.2196\/72054"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-023-00515-2"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2010.10.008"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/763680"},{"key":"e_1_3_3_42_1","unstructured":"41.GLP-1 Real World Efficacy | Dandelion Health Research. Dandelion Health. Available from: https:\/\/dandelionhealth.ai\/glp1-real-world-efficacy [Last accessed: May14 2026]."},{"key":"e_1_3_3_43_1","unstructured":"42.Cleveland Clinic research finds injectable medications for obesity produce smaller weight loss in a real-world setting compared to randomized clinical trials. Cleveland Clinic. Available from: https:\/\/newsroom.clevelandclinic.org\/2025\/06\/10\/cleveland-clinic-research-finds-injectable-medications-for-obesity-produce-smaller-weight-loss-in-a-real-world-setting-compared-to-randomized-clinical-trials [Last accessed: May21 2026]."},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16364"}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15209156261459741","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15209156261459741","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15209156261459741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:21:46Z","timestamp":1792264906000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15209156261459741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":43,"alternative-id":["10.1177\/15209156261459741"],"URL":"https:\/\/doi.org\/10.1177\/15209156261459741","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"article-number":"15209156261459741"}}